RT Journal Article
SR Electronic
T1 Comprehensive Review of Adverse Effects in Minimally Invasive Cosmetic Procedures: Insights from a Decade of Clinical Data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.23.24312506
DO 10.1101/2024.08.23.24312506
A1 Beltrán Muñoz, Cristina Guadalupe
A1 Perez, Elissa Bracamontes
A1 Bay, Fernanda Corrales
A1 Barajas Nieto, Aimee Adriana
A1 Rojo Navarro, Kate Georgette
YR 2024
UL http://medrxiv.org/content/early/2024/08/23/2024.08.23.24312506.abstract
AB Introduction Minimally invasive cosmetic procedures are medical interventions that do not involve the use of surgical incisions. They are usually based on the administration of biocompatible compounds into subcutaneous or dermal tissue. Although considered low-risk, they can have significant adverse effects such as tissue damage or occlusion of superficial blood vessels. Describing their complications is necessary to ensure the responsible use of these resources.Objective To describe the adverse effects secondary to the use of minimally invasive cosmetic procedures.Materials and Methods Studies describing the adverse effects of minimally invasive cosmetic procedures were searched in PubMed, Scopus, Embase, and Google Scholar from January 2012 to December 2023.Results A total of 98 articles were included. The administration of hyaluronic acid, botulinum toxin, silicone, and autologous fat grafts were the most commonly used procedures. Local symptoms were the most commonly reported reactions (53 studies). Meanwhile, temporary or permanent blindness was reported in 10 studies, immunological alterations in 8, severe pulmonary involvement in 6, neurological damage in 5, arterial occlusion in 3, and 2 studies reported fatalities.Conclusion Minimally invasive cosmetic procedures can cause local complications in the majority of cases, but they can also lead to fatal outcomes, particularly in unprofessional settings. Undergoing these techniques requires a comprehensive professional assessment and close follow-up by licensed personnel.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:PubMed, Embase, Scopus and Google Scholar open repositoriesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.